Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review.

European respiratory review : an official journal of the European Respiratory Society - 30 Sept 2020

Blanco Ignacio, Diego Isidro, Bueno Patricia, Pérez-Holanda Sergio, Casas-Maldonado Francisco, Miravitlles Marc

Abstract excerpt

The percentage of α1-antitrypsin protease inhibitor ZZ (PiZZ) genotypes in patients with COPD is controversial, with large differences among various studies. We aimed to estimate the prevalence of PiZZ in COPD patients from 20 European countries with available data, according to the number of PiZZ and COPD individuals in each country.A systematic review was conducted to select European countries with reliable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin Deficiency
Share to Europe

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Prevalence

Share to Pulmonary Disease, Chronic Obstructive

Source

Open in PubMed Open full text

Identifiers

PMID: 32699024
DOI: 10.1183/16000617.0014-2020
PMCID: PMC9489008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review.PMID 32699024Read ↗

Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease.Semantic proximity Read ↗

Rare alpha-1-antitrypsin variants: are they really so rare?Semantic proximity Read ↗

The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes.Semantic proximity Read ↗

Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.Semantic proximity Read ↗

Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease.Semantic proximity Read ↗

Frequency of alpha-1 antitrypsin deficiency and unexpected results in COPD patients in Turkey; rare variants are common.Semantic proximity Read ↗

Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases.Semantic proximity Read ↗

α1-Antitrypsin deficiency and chronic respiratory disorders.Semantic proximity Read ↗

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: Initial report of EARCOSemantic proximity Read ↗

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.Semantic proximity Read ↗

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.Semantic proximity Read ↗

Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.